Literature DB >> 22315141

Outcome measurement in behavioural sciences: a view on how to shift attention from means to individuals and why.

Luigi Tesio1.   

Abstract

Outcome studies in biomedical research usually focus on testing mean changes across samples of subjects and, in so doing, often obscure changes in individuals. These changes, however, may be very informative in studies in which large or homogeneous samples are unavailable and mechanisms of action are still under scrutiny, as is often the case for trials on new exercise treatments. Single measurements of change may be valid, provided that the reliability of the measurement process (i.e. instrument and procedure combined) was ascertained in a dedicated study in which appropriate statistical models and algorithms were applied. This article summarizes the conceptual steps that allow the calculation of the minimal real difference (MRD, also known as the minimal detectable change), on the basis of the assessment of reliability using an intraclass correlation coefficient. Individuals who show changes beyond the MRD can be reliably considered as changed. A numerical example of an MRD calculation is shown, and the pros and cons of the mean change and the MRD approach are discussed.

Mesh:

Year:  2012        PMID: 22315141     DOI: 10.1097/MRR.0b013e32834fbe89

Source DB:  PubMed          Journal:  Int J Rehabil Res        ISSN: 0342-5282            Impact factor:   1.479


  8 in total

1.  The impact of common mental disorders on work ability in mentally and physically demanding construction work.

Authors:  J S Boschman; H F van der Molen; M H W Frings-Dresen; J K Sluiter
Journal:  Int Arch Occup Environ Health       Date:  2012-12-20       Impact factor: 3.015

2.  Reference values for fatigued versus non-fatigued limb symmetry index measured by a newly designed single-leg hop test battery in healthy subjects: a pilot study.

Authors:  Iris Leister; Georg Mattiassich; Harald Kindermann; Reinhold Ortmaier; Jürgen Barthofer; Imre Vasvary; Klaus Katzensteiner; Christine Stelzhammer; Stefan Tino Kulnik
Journal:  Sport Sci Health       Date:  2017-11-10

3.  Is Fear of Harm (FoH) in Sports-Related Activities a Latent Trait? The Item Response Model Applied to the Photographic Series of Sports Activities for Anterior Cruciate Ligament Rupture (PHOSA-ACLR).

Authors:  Wim van Lankveld; Ron J Pat-El; Nicky van Melick; Robert van Cingel; J Bart Staal
Journal:  Int J Environ Res Public Health       Date:  2020-09-16       Impact factor: 3.390

4.  Quantitative evaluation of upper limb ataxia in spinocerebellar ataxias.

Authors:  Yoshiyuki Kishimoto; Atsushi Hashizume; Yuta Imai; Masahiro Nakatochi; Shinichiro Yamada; Daisuke Ito; Ryota Torii; Yoshitaka Nagano; Hideo Fujimoto; Masahisa Katsuno
Journal:  Ann Clin Transl Neurol       Date:  2022-03-15       Impact factor: 4.511

5.  A posteriori comparison of natural and surgical destabilization models of canine osteoarthritis.

Authors:  Maxim Moreau; Jean-Pierre Pelletier; Bertrand Lussier; Marc-André d'Anjou; Laurent Blond; Johanne-Martel Pelletier; Jérôme R E del Castillo; Eric Troncy
Journal:  Biomed Res Int       Date:  2013-10-31       Impact factor: 3.411

6.  Bimanual dexterity assessment: validation of a revised form of the turning subtest from the Minnesota Dexterity Test.

Authors:  Luigi Tesio; Anna Simone; Giuliano Zebellin; Viviana Rota; Calogero Malfitano; Laura Perucca
Journal:  Int J Rehabil Res       Date:  2016-03       Impact factor: 1.479

7.  Assessing the visual vertical: how many trials are required?

Authors:  C Piscicelli; S Nadeau; J Barra; D Pérennou
Journal:  BMC Neurol       Date:  2015-10-22       Impact factor: 2.474

8.  Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial.

Authors:  Paolo Zamboni; Luigi Tesio; Stefania Galimberti; Luca Massacesi; Fabrizio Salvi; Roberto D'Alessandro; Patrizia Cenni; Roberto Galeotti; Donato Papini; Roberto D'Amico; Silvana Simi; Maria Grazia Valsecchi; Graziella Filippini
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.